Patents by Inventor Yong-Chong Lin

Yong-Chong Lin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating pleural abnormality
    Patent number: 10219794
    Abstract: The invention relates to a method of treating pleural abnormalities in a subject in need thereof, comprising the steps of: (a) attaching a biodegradable polymeric membrane onto a pleural wound to elicit fibronectin from fibroblasts to cause fibrous adhesion; and (b) securing the membrane with securement products, including sutures, staples, and sealants. The present invention also relates to a biodegradable adhesion membrane used for treating pleural abnormalities, comprising: a biodegradable base material selected from the group consisting of polycaprolactone (PCL), polylactic acid or polylactide (PLA), polyhydroxybutyrate (PHB), poly(ethylene adipate), poly(butylene adipate) (PBA), chitosan, hyaluronic acid, and polyglycolic acid (PGA); wherein the thickness of the membrane is 0.1-1 mm.
    Type: Grant
    Filed: July 22, 2015
    Date of Patent: March 5, 2019
    Assignee: National Taiwan University
    Inventors: Tai-Horng Young, Jin-Shing Chen, Hong-Shiee Lai, Ke-Cheng Chen, Ya-Shuan Chou, Yong-Chong Lin, Hao-Ying Hsieh, Hsu-Hsien Chang
  • METHOD OF TREATING PLEURAL ABNORMALITY
    Publication number: 20160022878
    Abstract: The invention relates to a method of treating pleural abnormalities in a subject in need thereof, comprising the steps of: (a) attaching a biodegradable polymeric membrane onto a pleural wound to elicit fibronectin from fibroblasts to cause fibrous adhesion; and (b) securing the membrane with securement products, including sutures, staples, and sealants. The present invention also relates to a biodegradable adhesion membrane used for treating pleural abnormalities, comprising: a biodegradable base material selected from the group consisting of polycaprolactone (PCL), polylactic acid or polylactide (PLA), polyhydroxybutyrate (PHB), poly(ethylene adipate), poly(butylene adipate) (PBA), chitosan, hyaluronic acid, and polyglycolic acid (PGA); wherein the thickness of the membrane is 0.1-1 mm.
    Type: Application
    Filed: July 22, 2015
    Publication date: January 28, 2016
    Applicant: NATIONAL TAIWAN UNIVERSITY
    Inventors: Tai-Horng Young, Jin-Shing Chen, Hong-Shiee Lai, Ke-Cheng Chen, Ya-Shuan Chou, Yong-Chong Lin, Hao-Ying Hsieh, Hsu-Hsien Chang